Buyer Name: Great Western Hospitals NHS Foundation Trust
Buyer Address: Marlborough Road, Swindon, UKK14, SN3 6BB, United Kingdom
Contact Name: BSW Procurement helpdesk
Contact Email: support@salisburyfoundationtrust-support.freshdesk.com
Buyer Name: Great Western Hospitals NHS Foundation Trust
Buyer Address: Marlborough Road, Swindon, UKK14, SN3 6BB, United Kingdom
Contact Name: BSW Procurement helpdesk
Contact Email: support@salisburyfoundationtrust-support.freshdesk.com
This is direct award to Oxford University Hospital NHS Foundation Trust (referred to as OUH), for the provision of pathology diagnostic testing under the Provider Selection Regime (PSR) "Most Suitable Provider". This is an inter-NHS contract award.<br/><br/>As shown in the disclosed criteria, the main weighted criteria, Integration, collaboration and service is<br/>weighted at 50% as the key objective to centralise testing within the S4 pathology network, connected via LIMs. The other elements of quality-led criteria total a further 40% of the weighting. Value in terms of cost<br/>has been weighted at 10%, because integration, and maintaining the quality of the service is the main objective.
No linked documents found for this notice.
Lot Description: This is a direct award to Oxford University Hospital NHS Foundation Trust (OUH) under the<br/>Provider Selection Regime (PSR) using the "Most Suitable Provider" process. The contract is for the provision of pathology diagnostic testing currently outsourced within the NHS. <br/>As per the NHSE strategy to deliver cost effective pathology services and build resilience, improve internal delivery and deliver social value, GWH will be repatriating some of its existing outsourced testing within its NHS partners for Immunology/Haematology /Blood sciences into the S4 Pathology network hub. <br/><br/>English Trusts are divided into various pathology networks with a central hub arrangement. GWH is part of S4. The network participants are connected via Lims which went Live for GWH in May 2025.<br/><br/>The contract term is for one year, from 06/06/2025 to 05/06/2026. <br/><br/>The estimated contract value for one year is £2,400,000. This contract value is a forecast only. The value of the contract is determined by the test type, actual test volume and driven by patient need. Contract value for 25025/2026 will be subject to benchmark prior to contract expiry. <br/><br/>As shown in the disclosed criteria, the main weighted criteria, Integration, Collaboration and Service is<br/>weighted at 50%, as the key objective to centralise testing within the S4 pathology network, connected via LIMs. The other elements of quality-led criteria total a further 40% of the weighting. Value in terms of cost<br/>has been weighted at 10% because integration, and maintaining the quality of the service is the main objective. <br/><br/>GWH will be awarding this contract under PSR “Most suitable provider” as OUH are the only organisation that is a) part of the S4 pathology network and therefore fulfils NHSE strategic requirements for a future pathology service b) as the hub lead, can deliver the testing required c) from May 2025, will be connected to OUH via LIMs.<br/><br/>OUH already deliver part of the testing requirement under existing arrangements. University Hospital Southampton NHS Foundation Trust (referred to as UHS) also provide pathology testing services to GWH under long term contractual arrangements. GWH are awarding this under the PSR regime as the “Most Suitable provider” as OUH is a) the hub lead and b) connected to GWH via LIMs. GWH will no longer be able to transfer those tests via any other route. UHS are supporting GWH as part of the transfer of the work into OUH. This process will therefore centralise the inter NHS testing under one contract.
Lot 1 Status: cancelled
Lot 1 Has Options: No
Lot 1 Award Criterion (quality): Integration, collaboration and service sustainability
Lot 1 Award Criterion (quality): Improving access, reducing health inequalities and facilitating choice
Lot 1 Award Criterion (quality): Quality and Innovation
Lot 1 Award Criterion (quality): Social Value
Lot 1 Award Criterion (cost): Value
{
"awards": [
{
"id": "026222-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148555",
"name": "OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
}
]
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"buyer": {
"id": "GB-FTS-161",
"name": "Great Western Hospitals NHS Foundation Trust"
},
"contracts": [
{
"awardID": "026222-2025-1",
"dateSigned": "2025-05-23T00:00:00+01:00",
"id": "026222-2025-1",
"status": "active",
"value": {
"amount": 2040000.0,
"currency": "GBP"
}
}
],
"date": "2025-05-23T12:37:56+01:00",
"description": "This is a Provider Selection Regime (PSR) intention to award notice (FO3). The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 4pm 5th June 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\u2019\u003cbr/\u003e\u003cbr/\u003eAny representations should be forwarded in the first instance to the BSW Procurement Helpdesk, support@salisburyfoundationtrust-support.freshdesk.com\u003cbr/\u003e\u003cbr/\u003eThe award decision makers are Noman Manzoor - Director of Pathology at Great Western\u003cbr/\u003eHospitals (GWH) and Rob Webb - Director of Procurement for BSW Alliance, on behalf of\u003cbr/\u003eGreat Western Hospitals (GWH). Both decision makers have confirmed they are not subject\u003cbr/\u003eto any conflict of interest and can demonstrate a clear and transparent application of the\u003cbr/\u003eservice criteria during their decision process.\u003cbr/\u003eThe decision process was based on a review of the requirement and the strategy involving OUH as described above against a set of 5 criteria with a total weighting of 100% as published.",
"id": "026222-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-052231",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Swindon",
"postalCode": "SN3 6BB",
"region": "UKK14",
"streetAddress": "Marlborough Road"
},
"contactPoint": {
"email": "support@salisburyfoundationtrust-support.freshdesk.com",
"name": "BSW Procurement helpdesk"
},
"details": {
"buyerProfile": "https://www.gwh.nhs.uk/",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.gwh.nhs.uk/"
},
"id": "GB-FTS-161",
"identifier": {
"legalName": "Great Western Hospitals NHS Foundation Trust"
},
"name": "Great Western Hospitals NHS Foundation Trust",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Oxford",
"postalCode": "OX3 9DU",
"region": "UKK",
"streetAddress": "John Radcliffe Hospital Headley Way Headington Oxford"
},
"details": {
"scale": "sme"
},
"id": "GB-FTS-148555",
"identifier": {
"id": "00000N/A",
"legalName": "OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
},
"name": "OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Salisbury",
"postalCode": "SP2 8BJ",
"streetAddress": "Salisbury NHS Foundation Trust, Odstock Road"
},
"details": {
"url": "https://www.salisbury.nhs.uk/"
},
"id": "GB-FTS-69447",
"identifier": {
"legalName": "Salisbury Managed Procurement Services"
},
"name": "Salisbury Managed Procurement Services",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pathology services",
"id": "85111800",
"scheme": "CPV"
},
"description": "This is direct award to Oxford University Hospital NHS Foundation Trust (referred to as OUH), for the provision of pathology diagnostic testing under the Provider Selection Regime (PSR) \"Most Suitable Provider\". This is an inter-NHS contract award.\u003cbr/\u003e\u003cbr/\u003eAs shown in the disclosed criteria, the main weighted criteria, Integration, collaboration and service is\u003cbr/\u003eweighted at 50% as the key objective to centralise testing within the S4 pathology network, connected via LIMs. The other elements of quality-led criteria total a further 40% of the weighting. Value in terms of cost\u003cbr/\u003ehas been weighted at 10%, because integration, and maintaining the quality of the service is the main objective.",
"id": "ocds-h6vhtk-052231",
"items": [
{
"deliveryAddresses": [
{
"region": "UKK"
}
],
"deliveryLocation": {
"description": "Oxford University Hospital NHS Foundation Trust\u003cbr/\u003eHeadley Way, \u003cbr/\u003eOxford\u003cbr/\u003eOX3 9DU"
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "50%",
"name": "Integration, collaboration and service sustainability",
"type": "quality"
},
{
"description": "20%",
"name": "Improving access, reducing health inequalities and facilitating choice",
"type": "quality"
},
{
"description": "10%",
"name": "Quality and Innovation",
"type": "quality"
},
{
"description": "10%",
"name": "Social Value",
"type": "quality"
},
{
"description": "10%",
"name": "Value",
"type": "cost"
}
]
},
"description": "This is a direct award to Oxford University Hospital NHS Foundation Trust (OUH) under the\u003cbr/\u003eProvider Selection Regime (PSR) using the \"Most Suitable Provider\" process. The contract is for the provision of pathology diagnostic testing currently outsourced within the NHS. \u003cbr/\u003eAs per the NHSE strategy to deliver cost effective pathology services and build resilience, improve internal delivery and deliver social value, GWH will be repatriating some of its existing outsourced testing within its NHS partners for Immunology/Haematology /Blood sciences into the S4 Pathology network hub. \u003cbr/\u003e\u003cbr/\u003eEnglish Trusts are divided into various pathology networks with a central hub arrangement. GWH is part of S4. The network participants are connected via Lims which went Live for GWH in May 2025.\u003cbr/\u003e\u003cbr/\u003eThe contract term is for one year, from 06/06/2025 to 05/06/2026. \u003cbr/\u003e\u003cbr/\u003eThe estimated contract value for one year is \u00a32,400,000. This contract value is a forecast only. The value of the contract is determined by the test type, actual test volume and driven by patient need. Contract value for 25025/2026 will be subject to benchmark prior to contract expiry. \u003cbr/\u003e\u003cbr/\u003eAs shown in the disclosed criteria, the main weighted criteria, Integration, Collaboration and Service is\u003cbr/\u003eweighted at 50%, as the key objective to centralise testing within the S4 pathology network, connected via LIMs. The other elements of quality-led criteria total a further 40% of the weighting. Value in terms of cost\u003cbr/\u003ehas been weighted at 10% because integration, and maintaining the quality of the service is the main objective. \u003cbr/\u003e\u003cbr/\u003eGWH will be awarding this contract under PSR \u201cMost suitable provider\u201d as OUH are the only organisation that is a) part of the S4 pathology network and therefore fulfils NHSE strategic requirements for a future pathology service b) as the hub lead, can deliver the testing required c) from May 2025, will be connected to OUH via LIMs.\u003cbr/\u003e\u003cbr/\u003eOUH already deliver part of the testing requirement under existing arrangements. University Hospital Southampton NHS Foundation Trust (referred to as UHS) also provide pathology testing services to GWH under long term contractual arrangements. GWH are awarding this under the PSR regime as the \u201cMost Suitable provider\u201d as OUH is a) the hub lead and b) connected to GWH via LIMs. GWH will no longer be able to transfer those tests via any other route. UHS are supporting GWH as part of the transfer of the work into OUH. This process will therefore centralise the inter NHS testing under one contract.",
"hasOptions": false,
"id": "1",
"status": "cancelled"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice (F03) . The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. GWH intends to observe a standstill period of eight working days. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 4pm 5th June 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR\u0027.",
"procurementMethodRationaleClassifications": [
{
"description": "The procurement falls outside the scope of application of the directive",
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "Contract for the provision of pathology diagnostic testing (S4 network)"
}
}